Vu Quan Anh
Chief Financial Officer
Vu Quan Anh has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Oct 2, 2026.
On the most recent filing, Vu Quan Anh is listed as Chief Financial Officer at Monopar Therapeutics. Inside the rolling window, Vu Quan Anh reported 1 open-market purchase totaling $105K in MNPR and no open-market sales.
Companies traded
Other insiders at MNPR
Insider Buying
$105K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Vu Quan Anh made?
Vu Quan Anh has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Vu Quan Anh trade?
Vu Quan Anh has filed SEC Form 4 disclosures for 1 company, including MNPR.
When was Vu Quan Anh's most recent SEC Form 4 filing?
Vu Quan Anh's most recent SEC Form 4 filing on Tracefour is dated Oct 2, 2026.
What is Vu Quan Anh's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Vu Quan Anh is listed as Chief Financial Officer.
What is Vu Quan Anh's total buy and sell value in the current window?
Inside the rolling retention window, Vu Quan Anh bought $105K and sold $0 based on SEC Form 4 filings.
What was Vu Quan Anh's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,500 MNPR shares on 2025-12-26, worth $105K, per SEC Form 4 filings.